Fragmented by Design: How Incompatible Medical Devices Are Complicating Home Healthcare

When Margaret Okafor, a retired schoolteacher from Columbus, Ohio, was discharged from the hospital following a cardiac event, she returned home with three new devices: a continuous glucose monitor, a portable pulse oximeter, and a blood pressure cuff — each prescribed by a different specialist. Within a week, she discovered that none of them communicated with the same app. Two required proprietary charging cables she had to order separately. The third transmitted data in a format her primary care physician's electronic health record system could not read.

"I felt like I needed an IT degree just to manage my own health," she said.

Margaret's experience is far from unusual. Across the United States, patients managing multiple chronic conditions are quietly navigating a maze of incompatible connectors, siloed software platforms, and proprietary ecosystems — a fragmentation that costs them time, money, and occasionally their safety.

The Scope of the Problem

The home medical device market has expanded dramatically over the past decade. Remote patient monitoring, wearable diagnostics, and connected infusion systems have transformed what is possible outside a clinical setting. Yet this growth has outpaced any coherent effort at standardization.

Unlike consumer electronics — where USB-C adoption has created at least partial harmony — the medical device sector operates under a patchwork of competing standards. A CPAP machine from one manufacturer may require a proprietary humidifier chamber that is physically incompatible with a competing brand's unit. A wound care pump may use a data protocol that no third-party health app can interpret. An insulin delivery system may lock its dosing history behind a manufacturer portal that does not export to the patient's preferred format.

According to a 2023 report from the Office of the National Coordinator for Health Information Technology, interoperability gaps remain one of the most persistent barriers to effective home-based care. Patients who manage four or more devices — a common threshold for individuals with conditions such as diabetes, heart failure, or COPD — are statistically more likely to experience care coordination failures than those who manage fewer.

Why Manufacturers Resist Standardization

The answer, as is often the case, involves economics.

Proprietary ecosystems are extraordinarily profitable. When a patient purchases a continuous glucose monitor, they are not simply buying a device — they are entering a supply chain. The sensors, transmitters, and compatible receivers that follow represent recurring revenue for the manufacturer. Opening that ecosystem to third-party components would, from a business perspective, dilute that revenue stream considerably.

Manufacturers also argue, with some legitimacy, that proprietary integration allows for tighter quality control. A company that controls every component in its system can more reliably predict how that system will perform and can more precisely define the liability boundaries when something goes wrong. Standardization, they contend, introduces variables that are difficult to validate.

Regulators have historically been reluctant to mandate compatibility requirements, partly because the FDA's device approval framework is oriented toward individual product safety rather than systemic interoperability. A device can be cleared for market as long as it performs its stated function safely — whether or not it plays well with the six other devices on a patient's nightstand is largely outside the regulatory scope.

The Real Costs Patients Bear

The financial dimension of incompatibility is frequently underestimated. Patients who discover mid-treatment that their devices do not integrate may be forced to purchase redundant equipment, pay out of pocket for third-party data aggregation services, or replace recently acquired devices with alternatives from a single manufacturer's ecosystem. Insurance coverage for these replacement purchases is inconsistent at best.

Beyond dollars, there is a cognitive load that falls disproportionately on older patients and those with limited technical literacy. Managing multiple apps, multiple charging systems, and multiple data portals is not merely inconvenient — it is a genuine barrier to adherence. When the friction of using a device is high enough, patients simply stop using it.

There are also direct safety implications. When devices do not communicate, clinicians lose visibility. A cardiologist reviewing a patient's remote monitoring data may be seeing only a fraction of the physiological picture. Dosing decisions, escalation thresholds, and care plan adjustments made on incomplete data carry inherent risk.

What Regulatory Reform Could Accomplish

A number of policy advocates and health technology researchers have begun pushing for a more assertive federal stance on device interoperability. The 21st Century Cures Act, passed in 2016, made significant strides in mandating electronic health record interoperability for hospitals and health systems. Extending similar principles to home medical devices — requiring that data be exportable in standardized formats and that physical connection standards meet minimum compatibility requirements — would represent a meaningful step forward.

The FDA has signaled awareness of the issue. Its Digital Health Center of Excellence has explored frameworks for connected device oversight, and proposed guidance documents have begun to address software interoperability. However, binding requirements remain elusive, and the timeline for substantive regulatory change is measured in years, not months.

In the interim, some industry coalitions are pursuing voluntary standards. The Continua Design Guidelines, developed by the Personal Connected Health Alliance, offer a framework for health device interoperability that a number of manufacturers have adopted — though uptake remains inconsistent.

What Patients and Caregivers Can Do Now

While systemic reform works its way through regulatory channels, patients managing multiple home devices can take practical steps to reduce friction.

Before purchasing any new device, it is worth asking the following questions: Does this device transmit data to a platform my other devices already use? Does it export data in a standard format such as FHIR or HL7? What charging and connectivity standard does it require, and do I already own compatible accessories?

Speaking with a home healthcare coordinator — or, where available, a clinical pharmacist with expertise in connected health technology — before adding a new device to an existing regimen can prevent costly incompatibility discoveries after the fact. At AristoMedCart, our product listings include detailed compatibility notes precisely because we recognize that informed purchasing decisions depend on this kind of transparency.

Advocating with your care team also matters. Asking your physician to prescribe devices within a compatible ecosystem when clinically equivalent options exist is a reasonable request — and one that an increasing number of providers are prepared to accommodate.

A Call for Coherence

The home healthcare environment has become one of the most important sites of medical care delivery in the United States. Millions of Americans depend on devices in their homes to manage conditions that once required hospitalization. The systems supporting those patients deserve the same rigorous attention to interoperability that we expect of other critical infrastructure.

Fragmentation by design may serve short-term commercial interests. But it imposes long-term costs on patients, caregivers, and a healthcare system that can ill afford additional inefficiencies. The conversation about standards is no longer a niche technical debate — it is a patient safety conversation, and it is long overdue.